Clinical trial
Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis
NCT00301665 · Ipsen, Industry · Completed
Key facts
| NCT number | NCT00301665 |
|---|---|
| Title | Efficacy and Safety Study of Dysport® Used for Migraine Prophylaxis |
| Official title | A Phase II, Multicentre, Randomised, Double-blind, Parallel Groups, Placebo Controlled Clinical Study of Efficacy and Safety of Dysport® for Migraine Prophylaxis |
| Lead sponsor | Ipsen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine |
| Intervention type | Biological |
| Interventions | Botulinum toxin type A |
| Enrollment | 138 |
| Start date | Feb 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Mar 13, 2006 |
| Last update posted | Apr 24, 2020 |
| Countries | Czechia, Poland, Slovakia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: